Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoad...
- info372548
- Oct 15, 2018
- 1 min read
Multidisciplinary management is vital for borderline resectable pancreatic cancer.
Resection of borderline resectable pancreatic cancer is safe when performed by experienced surgeons at a high volume institution.
The rate of resection in patients with borderline pancreatic cancer is approximately 65%.
Surgical resection of borderline resectable pancreatic cancer is associated with improved overall survival.
Disease progression while receiving chemotherapy is the most frequent reason for unresectability. You can read the entire article here. A special thanks for this summary by Michael Wright, Department of Surgery, Johns Hopkins School of Medicine and Dr. Ammar Javed for his support.
Comments